Genotypic alterations associated with avirulence in streptomycin-resistant Pasteurella pestis

Journal of Bacteriology
|October 1, 1962
PubMed

Insights

New Pasteurella pestis genotypes causing avirulence were identified. These strains lost calcium (Ca++) dependence but retained virulence factors, offering insights into bacterial pathogenicity.

Area of Science:

  • Microbiology
  • Bacteriology
  • Genetics

Background:

  • Pasteurella pestis is a bacterium responsible for plague.
  • Avirulence in P. pestis is typically associated with the loss of virulence factors.
  • Streptomycin resistance is a common trait studied in bacterial pathogens.

Purpose of the Study:

  • To investigate genotypic alterations associated with avirulence in streptomycin-resistant Pasteurella pestis.
  • To characterize a novel genotype of P. pestis exhibiting avirulence despite possessing virulence factors.

Main Methods:

  • Selection of streptomycin-resistant Pasteurella pestis strains.
  • Cultivation on calcium (Ca++)-deficient media to observe colony morphology.
  • Assessment of virulence in mice and guinea pigs.
  • Genetic analysis of avirulent strains.

Main Results:

  • A new genotype of P. pestis was identified, characterized by avirulence and loss of Ca++ dependence, not loss of virulence antigens.
  • These new strains produced all four known virulence factors but were avirulent (LD50 > 10^8).
  • 20% of streptomycin-resistant isolates from virulent strains exhibited this new avirulent genotype.

Conclusions:

  • Avirulence in P. pestis can arise from genetic loss of Ca++ dependence, independent of virulence antigen production.
  • This finding challenges previous understandings of P. pestis avirulence mechanisms.
  • The study highlights the complexity of genetic determinants for virulence and avirulence in bacterial pathogens.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...